Isologic Innovative Radiopharmaceuticals (ISOLOGIC)
Stephane Martin has a wide range of experience in quality assurance and management roles. Stephane started their career in 1998 at Lantheus Medical Imaging as a Laboratory Technologist and later became a Quality Assurance Specialist II. In 2016, they joined IsoLogic Innovative Radiopharmaceuticals as a QA Manager for the PET network and then transitioned to the role of Associate Director of Quality. In 2018, they took on the role of Interim Vice President of CMC and Quality.
Stephane Martin obtained a DEC in Médecine nucléaire from Collège Ahuntsic in 1997. Following that, they pursued a Bacc in Biochimie from Université de Sherbrooke, graduating in 2002. Stephane furthered their studies at the same university and received a Maitrise in Pharmacologie in 2006.
This person is not in any offices
Isologic Innovative Radiopharmaceuticals (ISOLOGIC)
1 followers
Isologic Innovative Radiopharmaceuticals (ISOLOGIC) is a Canadian radiopharmaceutical company (nuclear pharmacy), dedicated to nuclear medicine and the science of Radiopharmaceutical production. Our commitment to these fields extends to the communities we serve. We utilize our significant experience, expertise and networks in Nuclear Pharmacy to provide our customers and patients with reliable; safe and high quality radiopharmaceutical products and services. ISOLOGIC’s network of SPECT & PET Radiopharmacies, positions us to service Group Purchase Organizations; regional health care systems, as well as stand-alone Independant Healthcare Facilities; clinics and hospitals. Our open formulary of Radiopharmaceutical drugs and medical devices, provides the flexibility of choice, providing our customers access to all radiopharmaceuticals, having Health Canada market authorization. En français : Isologic Innovative Radiopharmaceuticals (ISOLOGIC) est une entreprise radiopharmaceutique canadienne (pharmacie nucléaire), dédiée à la médecine nucléaire et à la science de la production radiopharmaceutique. Notre engagement dans ces domaines s'étend aux communautés que nous servons. Nous utilisons notre expérience, notre expertise et nos réseaux en pharmacie nucléaire pour fournir à nos clients et patients des produits et services radiopharmaceutiques fiables, sûrs et de haute qualité. Le réseau de radiopharmacies SPECT et PET d'ISOLOGIC nous permet de servir les organisations d'achats groupés, les systèmes de santé régionaux, ainsi que les établissements de santé indépendants, les cliniques et les hôpitaux. Notre formulaire ouvert de médicaments radiopharmaceutiques et de dispositifs médicaux offre la flexibilité du choix, en fournissant à nos clients l'accès à tous les produits radiopharmaceutiques, ayant une autorisation de mise sur le marché de Santé Canada.